United States · FDA National Drug Code directory
HERCESSI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69448-015_472e3da5-bba8-1d0e-e063-6394a90af880
- Product NDC
- 69448-015
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Trastuzumab-strf
- Labeler
- Accord BioPharma Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250101
- Source listing expiry
- 20261231
Source-listed ingredients
- TRASTUZUMAB-STRF — 150 mg/7.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (69448-015-05) / 7.4 mL in 1 VIAL, SINGLE-DOSE · 69448-015-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →